Evidence map›Paper›PMID 33743784›Full record

ArticleOrphanet journal of rare diseases2021

A standard set of outcome measures for the comprehensive assessment of osteogenesis imperfecta.

Wouter Nijhuis, Anton Franken, Kara Ayers, Chantal Damas, Lars Folkestad, Antonella Forlino, Paolo Fraschini, Claire Hill, Guus Janus, Richard Kruse and 17 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Early Life Management of Osteogenesis Imperfecta.Current osteoporosis reports · 2023
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 18 institutions in 13 countries.

Wouter NijhuisUniversity Medical Center Utrecht, Utrecht, The Netherlands. W.H.Nijhuis-2@umcutrecht.nl.ORCID 0000-0001-6683-7549
Anton FrankenIsala Zwolle, Utrecht, The Netherlands.
Kara AyersCincinnati Children's Hospital Medical Center, Cincinnati, USA.
Chantal DamasShriners Hospitals for Children, Montreal, Canada.
Lars FolkestadUniversity of Southern Denmark, Odense, Denmark.
Antonella ForlinoUniversity of Pavia, Pavia, Italy.
Paolo FraschiniRizzoli Institute Bologna, Milano, Italy.
Claire HillSheffields Children's NHS Trust Foundation, Sheffield, UK.
Guus JanusIsala Zwolle, Utrecht, The Netherlands.
Richard KruseNemours/Alfred Dupont Hospital for Children, Delaware, USA.
Lena Lande WekreTRS National Resource Center for Rare Disorders, Sunnaas Rehabilitation Hospital, Oslo, Norway.
Lieve MichielsZOI (Flemish OI Association), Brussels, Belgium.
Kathleen MontpetitAdvisor Care4BrittleBones Foundation, Montreal, Canada.
Leonardo PanzeriAS.IT.O.I. (Italian OI Association), Rome, Italy.
Valerie Porquet-BordesCHU de Toulouse, Toulouse, France.
Frank RauchShriners Hospitals for Children, Montreal, Canada.
Ralph SakkersUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Jean-Pierre SallesCHU de Toulouse, Toulouse, France.
Oliver SemlerDepartment of Paediatrics, University of Cologne, Cologne, Germany.
Jony SunChina-Dolls Center for Rare Disorders (CCRD), Bejing, China.
Michael ToThe University of Hong Kong - Shenzhen Hospital, Hong Kong SAR, Shenzhen, China.
Laura TosiChildren's National Hospital, Washington, USA.
Yangyang YaoShandong Provincial Hospital, Jihan, China.
Eric Hiu Kwong YeungThe University of Hong Kong - Shenzhen Hospital, Hong Kong SAR, Shenzhen, China.
Lidiia ZhytnikTartu University Hospital, Tartu, Estonia.
Maria Carola ZillikensUniversity Medical Center Erasmus Rotterdam, Rotterdam, The Netherlands.
Marjolein VerhoefUniversity Medical Center Utrecht, Utrecht, The Netherlands.
University Medical Center Utrecht · NLCentre Hospitalier Universitaire de Toulouse · FRIsala · NLShriners Hospitals for Children - Canada · CAUniversity of Hong Kong - Shenzhen Hospital · CNAlfred I. duPont Hospital for Children · USChildren's National · USCincinnati Children's Hospital Medical Center · USErasmus MC · NLFlemish Government · BEIstituto Ortopedico Rizzoli · ITShandong Provincial Hospital · CNSheffield Children's NHS Foundation Trust · GBSunnaas sykehus · NOTartu University Hospital · EEUniversity of Cologne · DEUniversity of Pavia · ITUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteogenesis Imperfecta (OI) is a genetic disorder also known as 'brittle bone disease'. The clinical manifestation of OI shows a wide variation. Therefore, care for patients with OI requires an interdisciplinary approach. The effectiveness of particular interventions and treatment protocols of interdisciplinary teams is not clear due to a non-standardized and wide variation of patient outcomes thus making the comparison of outcome measures available in the literature difficult. It is only by agreeing on a common, standard set of outcome measures for the comprehensive appraisal of OI that comparisons across interdisciplinary treatment centers for OI will be possible in the future.

methodsThe Key4OI international interdisciplinary working group of 27 members used a consensus-driven modified Delphi approach to develop a set of global outcome measures for patients with OI. The International Classification of Functioning, Disability and Health (ICF), was used to define domains and organize the outcomes from the literature search. After reviewing the outcomes extracted from the literature, trials and registries, the working group agreed on a final selection of domains and their definition (ICF definition as well as a lay description). These domains were then presented to the focus groups who prioritized the outcome domains by taking into account the items important to the OI community. All content was collected and analyzed and final domains were determined. A consensus of appropriate measuring instruments for each domain was reached with Delphi rounds. The entire approach was in line with the International Consortium for Health Outcomes Measurement ICHOM methodology.

resultsMore than 400 different outcome measures were identified in our literature search. After three Delphi rounds, 24 domains were selected. After the focus group sessions, the number of domains were reduced to 15. A consensus was reached on the measuring instruments to cover these domains for both children and adults.

conclusionThe Key4OI project resulted in standard set of outcome measures focused on the needs and wishes of individuals with OI and their families. This outcome set will enable healthcare teams and systems to compare and to improve their care pathways and quality of care worldwide. Further studies are needed to evaluate the implementation of this standardized outcome set.

Indexed as

Osteogenesis ImperfectaAdultChildConsensusFocus GroupsHumansOutcome Assessment, Health CareBrittle bone diseaseClinical outcome measuresContinuous quality improvementLearning health careOsteogenesis imperfectaOutcomesPatient-reported outcomes measuresValue-based health care

Identifiers

PMID33743784
PMCPMC7980586
OpenAlexW3137792553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.